Colibri Heart Valve, LLC is privately held and funded. Opportunities for investor participation are open periodically according to the company development schedule.
Colibri’s heart valve devices are in preclinical development. No devices or other products are currently offered for sale by the company. Discussion of the technical features of products under development do not in any way constitute claims for clinical effectiveness or pledges of future performance.
The information provided in this website does not constitute an offer of solicitation of securities in any state or other jurisdiction in which such an offer is not authorized. Any offering will be made only pursuant to an offering memorandum and after the offering has been registered or an exemption from registration has been obtained in compliance with applicable securities laws.